KabiCare
A program designed to support people using IDACIO®(adalimumab)
KabiCare
A program designed to support people using IDACIO®(adalimumab)
This program is only for patients currently using IDACIO®. By registering, you will have access to specially created information and tools which may help you:
- Increase your knowledge about your treatment
- Better understand your condition
- Manage the emotional ups and downs in your daily life associated with your condition
This program will be especially helpful if this is your first biologic medicine or if you have been switched to IDACIO® from another biologic.
You will need the unique code on the access card which is available from the doctor who prescribed your IDACIO®.
Register for access to KabiCareKabiCare is for people with an autoimmune disease
There are more than 80 types of autoimmune disorders.1 They occur when the immune cells in our body that usually fight ‘foreign invaders’ like bacteria and viruses start to attack the body’s own cells by mistake.2 This causes inflammation and damage.2 Autoimmune diseases can affect different areas of the body, for example the joints, the skin and the gut.2
A number of autoimmune conditions can be treated using biologics and biosimilars such as:3,4
• rheumatoid arthritis
• ankylosing spondylitis
• psoriasis and psoriatic arthritis
• inflammatory bowel disease
• hidradenitis suppurativa
You can find out more about your condition by registering for KabiCare.
What are biosimilars and biologics?
Biologic medicines contain substances made by living cells or organisms.4 They may be used to treat many long-term illnesses, including those caused by autoimmune disease.4 A biosimilar medicine is highly similar to a reference biologic medicine, which is the first brand to market.5 Biosimilar medicines are used to treat the same conditions, in the same way, as the reference biologic medicine.5 Approved biosimilar medicines have been tested and shown to be as safe and effective as reference biologic medicines.5
During its development, a biosimilar is studied in a number of different ways, as shown below.4
Before it can be given to patients, companies must show that a biosimilar is highly similar to the reference biologic medicine.4 Biosimilars will never be exactly the same as the reference biologic medicine.6 This is because biosimilars are complex and made by living cells, so will show some small differences while being made.6 Even with these small differences, it is important to know that because they are highly similar, there should be no meaningful differences in terms of effectiveness, safety and quality between the biosimilar and the reference biologic medicine.6
For more details, join KabiCare.
You will need the unique code provided on the access card,
available from the doctor who prescribed your IDACIO®.
References used in the preparation of this webpage
1. Campbell AW. Autoimmunity and the gut. Autoimmune Dis 2014; 152428.
2. Autoimmune diseases: Types, symptoms, causes and more. Available at www.healthline.com/health/autoimmune-disorders [Accessed December 2020]
3. IDACIO® Approved Product Information.
4. The Department of Health Biosimilar Awareness Initiative. Biosimilar medicines: the basics for health care professionals. Available at: www1.health.gov.au/internet/main/publishing.nsf/Content/biosimilar-awareness-initiative?Open=&utm_source=health.gov.au&utm_medium=redirect&utm_campaign=digital_transformation&utm_content=biosimilars [Accessed December 2020]
5. The Department of Health Biosimilar Awareness Initiative. Biosimilar medicines: the basics for consumers and carers. Available at:www1.health.gov.au/internet/main/publishing.nsf/Content/biosimilar-awareness-initiative?Open=&utm_source=health.gov.au&utm_medium=redirect&utm_campaign=digital_transformation&utm_content=biosimilars [Accessed December 2020]
6. The Department of Health. What are biosimilar medicines? Available at: www1.health.gov.au/internet/main/publishing.nsf/Content/biosimilar-what-are-biosimilar-medicines [Accessed December 2020]